Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy

AIMS: As evidenced by scintigraphy imaging, the prevalence of transthyretin (TTR) cardiac amyloidosis in heart failure patients with preserved ejection fraction (HFpEF) and left ventricular hypertrophy (LVH) ranges between 13% and 19%. The natural evolution of cardiac amyloidosis begins with the dep...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ESC Heart Fail
Päätekijät: Devesa, Ana, Camblor Blasco, Andrea, Pello Lázaro, Ana María, Askari, Elham, Lapeña, Gregoria, Gómez Talavera, Sandra, Taibo Urquía, Mikel, Rodríguez Olleros, Celia, Tuñón, José, Ibáñez, Borja, Aceña, Álvaro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Original Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318443/
https://ncbi.nlm.nih.gov/pubmed/33963812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13360
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia